−0.86 PLN
−11.21 M PLN
1.00 K PLN
About Genomtec SA
Sector
Industry
CEO
Miron Tokarski
Website
Headquarters
Wroclaw
Founded
2016
ISIN
PLGNMTC00017
FIGI
BBG00ZNLD9P9
Genomtec SA engages in the research and development of molecular diagnostic equipment. It offers mobile molecular analyzer. The company was founded by Miron Tokarski, Malgorzata Malodobra-Mazur, and Henryk Roguszczak in December 2016 and is headquartered in Wroclaw, Poland.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of GMT is 6.84 PLN — it has increased by 1.16% in the past 24 hours. Watch Genomtec SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GPW exchange Genomtec SA stocks are traded under the ticker GMT.
GMT stock has risen by 8.36% compared to the previous week, the month change is a 18.64% rise, over the last year Genomtec SA has showed a −9.88% decrease.
GMT stock is 3.08% volatile and has beta coefficient of −0.37. Track Genomtec SA stock price on the chart and check out the list of the most volatile stocks — is Genomtec SA there?
Today Genomtec SA has the market capitalization of 105.45 M, it has increased by 7.33% over the last week.
Yes, you can track Genomtec SA financials in yearly and quarterly reports right on TradingView.
GMT net income for the last quarter is −3.21 M PLN, while the quarter before that showed −1.88 M PLN of net income which accounts for −70.30% change. Track more Genomtec SA financial stats to get the full picture.
No, GMT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 25, 2025, the company has 22 employees. See our rating of the largest employees — is Genomtec SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Genomtec SA EBITDA is −11.59 M PLN, and current EBITDA margin is −1.11 M%. See more stats in Genomtec SA financial statements.
Like other stocks, GMT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Genomtec SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Genomtec SA technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Genomtec SA stock shows the sell signal. See more of Genomtec SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.